Adicon Holdings Limited

Equities

9860

KYG0086A1076

Healthcare Facilities & Services

Market Closed - Hong Kong S.E. Other stock markets 01:38:25 16/01/2026 pm IST			5-day change	1st Jan Change
5.100 ^HKD	-3.23%		+8.51%	+20.57%

06/01	EXECUTIVE CHANGE SUMMARY: Prospex Energy appoints Tom Reynolds as CEO	AN
14/11	Adicon Unit to Acquire Crown Bioscience for Up to $204 Million; Shares Fall 8%	MT

Tranche Update on Adicon Holdings Limited's Equity Buyback Plan announced on June 10, 2024.

Published on 03/31/2025 at 02:02 pm IST

S&P Capital IQ

Adicon Holdings Limited

-3.23%

From July 1, 2024 to December 31, 2024, the company has repurchased 0 shares, representing 0% for HKD 0 million. With this, the company has completed the repurchase of 1,611,500 shares, representing 0.25% for HKD 15.42 million under the buyback announced on June 10, 2024.

Latest news about Adicon Holdings Limited

06/01	EXECUTIVE CHANGE SUMMARY: Prospex Energy appoints Tom Reynolds as CEO	AN
14/11	Adicon Unit to Acquire Crown Bioscience for Up to $204 Million; Shares Fall 8%	MT
13/11	Adicon Holdings Limited entered into a definitive agreement to acquire Crown Bioscience, Inc. from Crown Bioscience International.	CI
09/11	ADICON Holdings Limited Announces Resignation of Zhu Jonathan as Non-Executive Director and Board Committee Member	CI
04/25/04	Tranche Update on Adicon Holdings Limited's Equity Buyback Plan announced on June 10, 2024.	CI
22/25/22	Adicon's Profit Slides in H1	MT
22/25/22	Adicon Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2025	CI
22/25/22	Adicon Holdings Limited Appoints Zhu Jonathan as Non-Executive Director and Member of the Strategy Committee of the Board, with Effect from August 22, 2025	CI
26/25/26	Adicon Holdings Limited's Equity Buyback announced on June 10, 2024, has expired with 1,711,500 shares, representing 0.26% for HKD 16.12 million.	CI
07/25/07	Adicon Holdings Acquires Two Medical Firms in Strategic Expansion Move	MT
06/25/06	Adicon Holdings Says Yuande Weikang Acquisition Valued At HKD191 Million	RE
06/25/06	Adicon Holdings Limited agreed to acquire Suzhou Yuande Weikang Biomedical Co., Ltd. from CHEN Jun for approximately CNY 200 million.	CI
31/25/31	Adicon Holdings Logs FY Profit Attributable RMB47.0 Mln	RE
31/25/31	Tranche Update on Adicon Holdings Limited's Equity Buyback Plan announced on June 10, 2024.	CI
31/25/31	Adicon Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2024	CI
19/24/19	ADICON Launches Share Buyback Program	MT
23/24/23	Adicon Holdings Limited(SEHK:9860) added to S&P Global BMI Index	CI
30/24/30	Tranche Update on Adicon Holdings Limited's Equity Buyback Plan announced on June 10, 2024.	CI
30/24/30	Adicon Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2024	CI
29/24/29	281,541,805 Ordinary Shares of Adicon Holdings Limited are subject to a Lock-Up Agreement Ending on 29-JUN-2024.	CI
10/24/10	Adicon Holdings Limited commences an Equity Buyback for 72,735,479 shares, representing 10% of its issued share capital, under the authorization approved on May 30, 2024.	CI
05/24/05	ADICON Holdings to Repurchase 5% of Shares	MT
30/24/30	Adicon Holdings Limited Approves Appointment of Mr. Zhou Mintao as A Non-Executive Director	CI
29/24/29	ADICON Holdings' 2023 Profit, Revenue Decline	MT
28/24/28	Adicon Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Chart Adicon Holdings Limited

Duration

Period

9860: Dynamic Chart

Company Profile

Adicon Holdings Ltd is an investment holding company principally engaged in the provision of independent clinical laboratory (ICL) services. The Company primarily provides testing services to hospitals, medical institutions, medical examination centers, consumers, pharmaceutical companies and contract research organizations (CROs). The Company's inspection services mainly include routine tests, esoteric tests, clinical immunologic testing, clinical chemistry testing, clinical molecular biology testing, pathology testing and others testing. The Company is also engaged in the sales of medical testing equipment. The Company principally conducts its businesses in the domestic market.

Employees

5,151

Sector

Healthcare Facilities & Services

Calendar

26/03 - Q4 2025 Earnings Release (Projected)

More about the company